Evidence map›Paper›PMID 34448415›Full record

ArticleAnnals of the Royal College of Surgeons of England2021

Prevalence and predictors of thyroid cancer among thyroid nodules: a retrospective cohort study of 1,000 patients.

S S Elbalka, I H Metwally, M Shetiwy, S Awny, O Hamdy, S Z Kotb, A M Shoman, E Shahda, I A Elzahaby

Abstract read
In one paragraph

Article in Annals of the Royal College of Surgeons of England, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

S S ElbalkaOncology Center Mansoura University, Mansoura, Egypt.
I H MetwallyOncology Center Mansoura University, Mansoura, Egypt.
M ShetiwyOncology Center Mansoura University, Mansoura, Egypt.
S AwnyOncology Center Mansoura University, Mansoura, Egypt.
O HamdyOncology Center Mansoura University, Mansoura, Egypt.
S Z KotbOncology Center Mansoura University, Mansoura, Egypt.
A M ShomanMansoura University Hospitals, Mansoura, Egypt.
E ShahdaMansoura University Hospitals, Mansoura, Egypt.
I A ElzahabyOncology Center Mansoura University, Mansoura, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThyroid cancer is increasing in incidence globally due either to early detection (overestimation) or true increment. A recent debate concerns multinodular goitre (MNG) or toxic goitres which have classically been considered at a lower risk for cancer.

methodsIn this study, we enrolled retrospectively all patients with nodular goitre treated at our tertiary hospital and analysed their data with the aim of detecting the rate of cancer among different types of nodular goitre. We also studied predictors of incidental malignancy among thyroidectomies.

resultsA predilection for solitary thyroid nodules (STNs) was found in women of younger age, with STNs tending to be larger in comparison with MNG in the same age group. However, both types of nodules were at equal risk of harbouring malignancy. Thyroid Imaging Reporting and Data System (TI-RADS) and Bethesda scores were the only dependent predictors of malignancy within thyroid nodules.

conclusionThe authors recommend management of both STNs and MNG using the same algorithm.

Indexed as

AdultCohort StudiesFemaleGoiter, NodularHumansMaleMiddle AgedPrevalencePrognosisRetrospective StudiesThyroid NeoplasmsThyroid NoduleFine-needle cytologyGoitreThyroid cancerThyroidectomyThyroid nodules

Identifiers

PMID34448415
PMCPMC10335314

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.